The work is a review of the methods of the surface modification performed by the authors dedicated for for cardiac support system. It presents the evolution of designing the surface dedicated to direct contact with blood. Initially thin and ultrathin coatings were developed. They were designed as a blood-polymer barrier. The pneumatic heart assist devices are made of a medical grade polyurethane. A major milestone was to create advanced ceramic thin films expressing the flexible effects deposited by physical techniques. Coatings have evolved. Another milestone was the surface reproducing the microenvironment to capture progenitor cells from the bloodstream. Thin coatings were prepared, using methods of ion been, controlled residual stresses...
The future and the development of science is therefore seen in interdisciplinary areas such as biome...
The use of blood-contacting implantable devices is limited by surface-induced thrombosis, which has ...
Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and hold promise...
Cardiac medical devices (CMDs) are required when the patient’s cardiac capacity or activity is compr...
The work focused on developing functional coatings on titanium substrates that would facilitate the ...
Several methods have been developed to modify the surfaces of materials used in artificial hearts an...
The paper presents the main achievements of the author on the development of blood contacting materi...
Copyright © 2014 Saravana Kumar Jaganathan et al. This is an open access article distributed under t...
The development of implantable cardiac assist devices for prolonged circulatory support has been imp...
Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and inves...
Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and inves...
The phenomenon of blood coagulation on the surfaces of implantable devices such as artifi cial blood...
Prosthetic cardiac valves implantation is a common procedure used to treat heart valve diseases. Alt...
Abstract Background Due to the shortage of organs’ donors that limits biological heart transplantati...
International audienceVascular tissue engineering aims to develop implantable blood-vessels, exhibit...
The future and the development of science is therefore seen in interdisciplinary areas such as biome...
The use of blood-contacting implantable devices is limited by surface-induced thrombosis, which has ...
Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and hold promise...
Cardiac medical devices (CMDs) are required when the patient’s cardiac capacity or activity is compr...
The work focused on developing functional coatings on titanium substrates that would facilitate the ...
Several methods have been developed to modify the surfaces of materials used in artificial hearts an...
The paper presents the main achievements of the author on the development of blood contacting materi...
Copyright © 2014 Saravana Kumar Jaganathan et al. This is an open access article distributed under t...
The development of implantable cardiac assist devices for prolonged circulatory support has been imp...
Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and inves...
Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and inves...
The phenomenon of blood coagulation on the surfaces of implantable devices such as artifi cial blood...
Prosthetic cardiac valves implantation is a common procedure used to treat heart valve diseases. Alt...
Abstract Background Due to the shortage of organs’ donors that limits biological heart transplantati...
International audienceVascular tissue engineering aims to develop implantable blood-vessels, exhibit...
The future and the development of science is therefore seen in interdisciplinary areas such as biome...
The use of blood-contacting implantable devices is limited by surface-induced thrombosis, which has ...
Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and hold promise...